China's PBOC Injects 662.5 Billion Yuan via 7-Day Reverse Repos; Rate Held at 1.40%

The People's Bank of China (PBOC) injected 662.5 billion yuan into the financial system through 7-day reverse repurchase agreements, keeping the rate unchanged at 1.40%. The operation marked the largest single-day liquidity injection in recent weeks, surpassing the 524.5 billion yuan conducted on June 23 and the 420.3 billion yuan offered on June 16. Reverse repos function as the central bank's short-term liquidity tool. Under the operation, the PBOC purchases securities from commercial banks and agrees to sell them back after seven days, temporarily adding cash to the banking system. Injection sizes have risen steadily over the past several weeks—from 420.3 billion yuan on June 16 to 524.5 billion yuan a week later and now 662.5 billion yuan—an increase of roughly 58% over that span. While volumes have climbed, the price of funding has not. The 1.40% rate has been maintained across these operations, pointing to a focus on managing liquidity supply rather than signaling a change in policy rates. In addition to daily operations, the PBOC in mid-June conducted a 600 billion yuan outright reverse repo with a six-month tenor. The longer-dated injection suggests an effort to stabilize liquidity conditions beyond day-to-day needs. Short-term funding demand in China's banking system often rises around tax payment deadlines, heavy government bond issuance, and maturities of medium-term lending facilities—all of which can drain liquidity and prompt offsetting central bank operations. The PBOC did not reference digital assets or Bitcoin in relation to the latest injections. Past periods of sizable liquidity support have at times coincided with strength in Bitcoin and other risk assets, though correlation does not imply causation. Markets will also watch the 1.40% level closely. A rate cut would represent a clearer shift from targeted liquidity management toward broader easing. For now, the combination of a steady rate and rising operation sizes points to liquidity fine-tuning rather than a new policy direction.